The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early determination of benefit or futility in treating NSCLC using the LCSS 3-Item Global Index (3-IGI).
 
Richard J. Gralla
Honoraria - Chugai Pharma; Helsinn Healthcare; Merck; Mundipharma
Consulting or Advisory Role - Helsinn Healthcare; HERON
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Quality of life research associates
 
Patricia J Hollen
Patents, Royalties, Other Intellectual Property - Quality of life research associates
 
Richard Delmar Hall
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - Abbvie (Inst); Clovis Oncology (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Xcovery (Inst)
 
Ryan D. Gentzler
Honoraria - Merck
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
 
Haiying Cheng
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Novartis
 
Balazs Halmos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; Novartis; Pfizer; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Takeda
 
Jeffrey Crawford
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Celgene; Dova Pharmaceuticals; G1 Therapeutics; Janssen; Merck; Merrimack; Mylan; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech (Inst)
 
Martin Lesser
No Relationships to Disclose